Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood–
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flügel, T Wehner, M Boentert… - Nature …, 2001 - research.ed.ac.uk
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flügel, T Wehner, M Boentert… - Nature …, 2001 - pubmed.ncbi.nlm.nih.gov
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
[PDF][PDF] Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
A PERSONS, U DIRNAGL - NATURE MEDICINE, 2001 - researchgate.net
Number of GFP-expressing cells and percentage of ramified cells in the lesioned versus
control brain areas 14 d after transient focal cerebral ischemia, 12 d after fimbria-fornix …
control brain areas 14 d after transient focal cerebral ischemia, 12 d after fimbria-fornix …
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
J Priller, A Fluegel, T Wehner, M Boentert… - Nature …, 2001 - edoc.mdc-berlin.de
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
[引用][C] Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flügel, T Wehner, M Boentert, CA Haas… - Nature Medicine, 2001 - cir.nii.ac.jp
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green
fluorescent protein uncovers microglial engraftment | CiNii Research CiNii 国立情報学 …
fluorescent protein uncovers microglial engraftment | CiNii Research CiNii 国立情報学 …
Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.
J Priller, A Flügel, T Wehner, M Boentert, CA Haas… - Nature …, 2001 - europepmc.org
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flugel, T Wehner, M Boentert, CA Haas… - Nature Medicine, 2001 - go.gale.com
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood-
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment.
J Priller, A Flügel, T Wehner, M Boentert… - Nature …, 2001 - search.ebscohost.com
Gene therapy in the central nervous system (CNS) is hindered by the presence of the blood?
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
brain barrier, which restricts access of serum constituents and peripheral cells to the brain …
[引用][C] Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment
J Priller, A Flugel, T Wehner, M Boentert, CA Haas… - Nature Medicine, 2001 - pure.mpg.de
Targeting gene-modified hematopoietic cells to the central nervous system: Use of green
fluorescent protein uncovers microglial engraftment :: MPG.PuRe English Help Privacy Policy …
fluorescent protein uncovers microglial engraftment :: MPG.PuRe English Help Privacy Policy …